• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of Commercial Investigational New Drugs Applications (INDs)/Investigational Drug Exemptions (IDEs) received in the month (1)

Dictionary: This measure shows the number of commercial, research, and emergency INDs / IDEs received in the month. An IND / IDE application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs / IDEs reflect new products under development. Research INDs / IDEs reflect work that supports research and public health initiatives. Emergency INDs are requests to FDA, generally made by telephone, for an investigational drug to be used for the treatment of an individual patient by a licensed physician.

Information is current as of September 30, 2012

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Jul 2010N/A8
Aug 2010N/A13
Sep 2010N/A10

Footnotes

  • (1) Tracking against these measures did not start until July 2010

Number of Research IND/IDEs received in the month (1)

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Jul 2010N/A11
Aug 2010N/A14
Sep 2010N/A12

Number of Emergency IND/IDEs received in the month (1)

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Jul 2010N/A4
Aug 2010N/A1
Sep 2010N/A2

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.